Anupam Rasayan India
BSE 543275
14 stories, newest first.
- ESG rating intimation: Crisil assigns ESG 62 and Core ESG 63 (Strong)
- Anupam Rasayan India Ltd: 2.16% of shares pledged
- Promoter Mona Anandbhai Desai files updated encumbrance disclosure; pledges created and two released
- Promoter pledges shares as security for group debentures; 97.58% of her holding encumbered
- Anupam Rasayan India Ltd: 5.80% of shares pledged
- Promoter releases pledge on 50,00,000 shares, 4.39% of total share capital
- Promoter Mona Anandbhai Desai creates pledge on 14,60,625 equity shares
- Promoter and promoter group member create pledge on 31,40,000, 39,01,160 and 50,00,000 shares
- Clarification on acquisition of Bliss GVS Pharma shares: PAC holds 47.95% stake
- Promoter releases pledge on 33,40,000 shares after partial NCD redemption
- Anupam Rasayan India Ltd: 9.10% of shares pledged
- Anupam Rasayan's deputy CFO discussed the company's acquisition of a 50% stake in Bliss GVS Pharma, marking its entry into finished dosage pharmaceutical formulations
- Anupam Rasayan acquires control of Bliss GVS Pharma; buys 2.12% for Rs.162.74 crore, holding at 50.07%
- Concludes acquisition of 48.2% controlling stake in Bliss GVS Pharma at ₹299 per share
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.